ngµç×ÓÓÎÏ·ÐÂÎÅÍøÑ¶£¨Í¨Ñ¶Ô±ÆÕÓçù¡¢¡¢³Â¼Ñçù¡¢¡¢Áº¾°ºê£©¿ËÈÕ£¬ngµç×ÓÓÎÏ·¹«¹²ÎÀÉúѧԺ³ÂÑǾü½ÌÊÚÍŶӵÄÒ»ÏîÑо¿ÏÔʾ£¬È«ÇòԼĪÿÈýÃû¶ùͯÇàÉÙÄêÖоÍÓÐÒ»ÈË»¼ÓнüÊÓ£¬Ô¤¼Æµ½2050Ä꣬ÕâÒ»ÄêËê¶ÎµÄ½üÊÓ»¼²¡ÈËÊý½«Áè¼Ý7.4ÒÚÀý¡£¡£¡£¸ÃÑо¿×ÛºÏÁË1990ÄêÖÁ2023Äê¼ä£¬È«Çò50¶à¸ö¹ú¼Ò¡¢¡¢276ÏîÑо¿¡¢¡¢540¶àÍòÃû¶ùͯÇàÉÙÄêµÄÊý¾Ý£¬Í¬Ê±Í¨¹ýʱ¼äÐòÁÐÄ£×Ó׼ȷԤ²âÁËδÀ´30Äê¶ùͯÇàÉÙÄê½üÊÓ»¼²¡ÂʵÄ×ßÊÆ¡£¡£¡£¸ÃÑо¿Õ¹ÏÖÁËÈ«Çò½üÊÓÎÊÌâµÄÑÏËàÏÖ×´ºÍδÀ´¿ªÕ¹Ç÷ÊÆ£¬Îª¹«¹²ÎÀÉú¾öÒéÌṩÁËÖ÷ÒªÒÀ¾Ý¡£¡£¡£Ïà¹ØÐ§¹ûÒÔ¡°Global Prevalence, Trend and Projection of Myopia in Children and Adolescents from 1990 to 2050: A Comprehensive Systematic Review and Meta-analysis¡±ÎªÌâ½ÒÏþÔÚÑÛ¿ÆÁìÓòȨÍþÆÚ¿¯¡¶Ó¢¹úÑÛ¿ÆÑ§ÔÓÖ¾¡·¡£¡£¡£

ͼÐÎÕªÒª
Ä¿½ñ£¬½üÊÓÒѳÉΪȫÇò¹«¹²ÎÀÉúµÄÖØ´óÌôÕ½Ö®Ò»£¬Æä»¼²¡ÂÊÔÚ¶ùͯÇàÉÙÄêȺÌåÖÐѸËÙÅÊÉý¡£¡£¡£Ñо¿ÍŶӲο¼ÁË×èÖ¹2023Äê6ÔµÄ45,470ƪÏà¹ØÑо¿ºÍÕþ¸®±¨¸æ£¬»ùÓÚÑÏ¿áµÄÄÉÅűê×¼ºÍÖÊÁ¿ÆÀ¹À£¬×îºóÄÉÈëÁýÕÖÀ´×ÔÑÇÖÞ¡¢¡¢Å·ÖÞ¡¢¡¢·ÇÖÞ¡¢¡¢´óÑóÖÞ¡¢¡¢±±ÃÀºÍÀ¶¡ÃÀÖÞ50¸ö¹ú¼ÒµÄ276ÏîÑо¿£¬5,410,945Ãû¶ùͯÇàÉÙÄê£¬Éæ¼°1,969,090Ãû½üÊÓ²¡Àý¡£¡£¡£Ñо¿ÍŶÓÕûºÏÁËËùÓÐÕâЩÑо¿Êý¾Ý£¬²¢Ë¼Á¿Á˵ØÀí¡¢¡¢Ê±¼äÒÔ¼°ÆäËü±äÁ¿£¬Ê¹ÓÃËæ»úЧӦģ×ÓÔ¤¼Æ½üÊÓµÄ×ÜÌåÊ¢ÐÐÂʼ°Æäʱ¼äÇ÷ÊÆ£¬½ÓÄÉ×Իعé»ý·Ö»¬¶¯Æ½¾ùÄ£×ÓÔ¤²â2050ÄêÈ«Çò¶ùͯÇàÉÙÄê½üÊÓÊ¢ÐÐÂÊ£¬²¢Í¨¹ýµ÷½â©¶·Í¼ºÍEggerÄ¥Á·ÆÀ¹À½ÒÏþÆ«ÒС£¡£¡£
Ñо¿ÏÔʾ£¬È«Çò¶ùͯÇàÉÙÄê½üÊÓ»¼²¡ÂʵÄÔ¤¼ÆÖµÎª30.5%£¬²¢ÇÒÔÚÒÑÍù30Äê¼äÏÔÖøÔöÌí£¬´ÓÔ¼ËÄ·ÖÖ®Ò»ÔöÌíµ½ÏÖÔÚµÄÈý·ÖÖ®Ò»£º£º£º1990-2000ÄêÈ«Çò¶ùͯÇàÉÙÄê½üÊÓ»¼²¡ÂÊΪ24.3%£»2001-2010ÄêΪ25.3%£»2011-2019ÄêÔöÌíÖÁ29.7%£»2020-2023Äêʱ´ú£¬½üÊÓÂʸüÊǼ±¾çÅÊÉý£¬ÆäÖÐÇàÉÙÄêµÄ½üÊÓÂʸߴï54%¡£¡£¡£
¾¼Ã¿ªÕ¹Ë®Æ½¶Ô½üÊÓ»¼²¡ÂÊÓÐÏÔÖøÓ°Ï죬¿ªÕ¹Öйú¼Ò»ò²»Å¹ú¼ÒµÄ½üÊÓ»¼²¡ÂÊ£¨31.9%£©ÏÔןßÓÚÅ¹ú¼Ò£¨23.8%£©¡£¡£¡£ÆäÖУ¬ÑÇÖÞµØÇøµÄ½üÊÓ»¼²¡ÂÊ×î¸ß£¬µÖ´ï35.2%£»À¶¡ÃÀÖ޺ͼÓÀձȵØÇø×îµÍ£¬½öΪ3.8%¡£¡£¡£ÔÚ±¾Ñо¿°üÀ¨µÄ50¸ö¹ú¼ÒÖУ¨Í¼2£©£¬ÈÕ±¾µÄ¶ùͯÇàÉÙÄê½üÊÓ»¼²¡ÂÊ×î¸ß£¨86.0%£©£¬Æä´ÎÊǺ«¹ú£¨73.9%£©¡¢¡¢¶íÂÞ˹£¨46.2%£©ºÍÐÂ¼ÓÆÂ£¨44.1%£©£»ÖйúÅÅÔÚµÚÎåλ£¬Îª41.1%¡£¡£¡£
½üÊÓ»¼²¡ÂÊÔÚÄêËê¡¢¡¢ÐÔ±ðºÍµØÇø·½Ãæ²î±ðÒ²ºÜÊÇÏÔ×Å¡£¡£¡£ÕûÌå¶øÑÔ£¬ÇàÉÙÄêµÄ½üÊÓ»¼²¡ÂʸßÓÚ¶ùͯ£¬Ðè×¢ÖØµÄÊÇ£¬´Ó1990Äêµ½2023Ä꣬¶ùͯ½üÊÓ»¼²¡Âʵľø¶ÔÔöÌíÂÊԼΪÇàÉÙÄêµÄÁ½±¶¡£¡£¡£ÐÔ±ð·½Ã棬Ůº¢µÄ½üÊÓ»¼²¡ÂÊ£¨33.6%£©ÂÔ¸ßÓÚÄк¢£¨30.5%£©£¬ÆäÖÐÇà´ºÆÚÅ®º¢µÄ½üÊÓ»¼²¡Âʵִï48.8%£»ÑÇÖÞÅ®º¢µÄ½üÊÓ»¼²¡ÂÊ£¨37.7%£©¸ßÓÚÑÇÖÞÄк¢£¨34.3%£©£¬Æä´ÎÊDZ±ÃÀÖÞÅ®º¢£¨26.9%£©ºÍ±±ÃÀÖÞÄк¢£¨24.1%£©¡£¡£¡£³ÇÏç²î±ð·½Ã棬³ÇÊеØÇø¶ùͯÇàÉÙÄêµÄ½üÊÓ»¼²¡ÂʸßÓÚÅ©´å£¬²¢ÇÒ³ÇÊÐÅ®º¢µÄ½üÊÓ»¼²¡ÂÊ£¨32.0%£©¸ßÓÚÄк¢£¨29.4%£©¡£¡£¡£

È«Çò¶ùͯÇàÉÙÄê½üÊÓ»¼²¡ÂÊÇéÐÎ
ÖйúÇéÐΣº£º£ºÑо¿ÍŶӶÔÖйú¶ùͯÇàÉÙÄê½üÊÓÇéÐξÙÐÐÁ˵¥¶ÀÆÊÎö£¬Í¼3ÏÔʾÁËÖйú¶ùͯÇàÉÙÄêµÄ½üÊÓ»¼²¡ÂÊÇéÐΡ£¡£¡£±¾Ñо¿¹²Éæ¼°1,891,986ÃûÖйú¶ùͯÇàÉÙÄ꣬ÆäÖÐ4,294,116Ãû»¼ÓнüÊÓ¡£¡£¡£ÕûÌå¶øÑÔ£¬1990Äêµ½2023ÄêÖйú¶ùͯÇàÉÙÄêµÄ½üÊÓ×Ü»¼²¡ÂÊΪ41.1%¡£¡£¡£²î±ðµØÇø¶ùͯÇàÉÙÄê½üÊÓ»¼²¡ÂÊÓÐËù²î±ð£¬¶«²¿µØÇø½üÊÓ»¼²¡ÂÊ×î¸ß£¬Îª46.3%£»Æä´ÎÊÇÎ÷²¿£¨37.8%£©ºÍÖв¿µØÇø£¨37.1%£©£»ÌØÊâÐÐÕþÇø£¨±¾Ñо¿½öÉæ¼°ÖйúÏã¸ÛºÍÖйų́ÍåµØÇø£©Îª31.3%£»¶«±±²¿µØÇøÎª28.0%¡£¡£¡£¹ØÓÚÐÔ±ð²î±ð£¬ÕûÌåÉÏÅ®º¢µÄ½üÊÓ»¼²¡ÂÊ£¨43.7%£©¸ßÓÚÄк¢£¨39.7%£©£¬Êý¾ÝÏÔʾÓÈÆäÊǹãÎ÷Å®º¢µÄ½üÊÓ»¼²¡ÂʵִïÁË72.9%£¬Æä´ÎÊǽËÕÅ®º¢£¨67.4%£©ºÍÉÂÎ÷Å®º¢£¨61.7%£©¡£¡£¡£
δÀ´Ô¤²â£º£º£ºÆ¾Ö¤Ô¤²âÆÊÎöЧ¹û£¨±í1£©£¬2030ÄêÈ«Çò¶ùͯÇàÉÙÄêµÄ½üÊÓ»¼²¡Âʽ«µÖ´ï32.2%£¬Ô¤¼ÆÓ°Ïì½ü6ÒÚ¶ùͯÇàÉÙÄꣻ2040Äê½üÊÓ»¼²¡Âʽ«ÉÏÉýÖÁ36.6%£¬Ô¤¼ÆÓ°ÏìÁè¼Ý6.6ÒÚ¶ùͯÇàÉÙÄꣻ2050Äê½üÊÓ»¼²¡Âʽ«¼ÌÐøÉÏÉýÖÁ39.8%£¬Ô¤¼ÆÓ°ÏìÁè¼Ý7.4ÒÚ¶ùͯÇàÉÙÄê¡£¡£¡£Ïà½ÏÓÚÄк¢£¬Å®º¢µÄ½üÊÓ»¼²¡ÂÊÔ¤¼Æ¸ü¸ß£¬2050Ä꽫´ï42.0%¡£¡£¡£Óë6-12Ëê¶ùͯÏà±È£¬13-19ËêÇàÉÙÄêµÄ½üÊÓ»¼²¡ÂÊÔ¤¼ÆÏÔןü¸ß£¬2050Äê¿ÉÄܸߴï52.4%¡£¡£¡£ÓëÅ¹ú¼ÒÏà±È£¬¿ªÕ¹Öйú¼Ò»ò²»Å¹ú¼ÒµÄ¶ùͯÇàÉÙÄêÔ¤¼ÆÓиü¸ßµÄ½üÊÓ»¼²¡ÂÊ£¬2050Ä꽫µÖ´ï40.8%£»²¢ÇÒÑÇÖÞ½«ÊǽüÊÓ»¼²¡ÂÊ×î¸ßµÄµØÇø£¬2050ÄêÔ¤¼Æ»¼²¡ÂÊΪ68.8%¡£¡£¡£
±í1 2030-2050ÄêÈ«Çò¶ùͯÇàÉÙÄê½üÊÓÊ¢ÐÐÇ÷ÊÆÔ¤²âÆÊÎö

±¾Ñо¿»ã×ÜÁËÈ«Çò¹æÄ£ÄÚ¶ùͯÇàÉÙÄê½üÊÓ»¼²¡ÂʵÄ×îÐÂÖ¤¾Ý£¬½ÓÄÉϵͳÐÔÒªÁì×ÛºÏÁ˹ØÓÚ½üÊÓ×ÜÌ廼²¡ÂʵÄÏêϸÊý¾Ý£¬ÆÊÎöÆäÊ¢ÐÐÇ÷ÊÆ²¢¾ÙÐÐδÀ´Ô¤²â¡£¡£¡£Ñо¿Í»³öÁËÈ«Çò²î±ðµØÇø¶ùͯÇàÉÙÄê½üÊÓ»¼²¡ÂʵIJî±ð£¬²¢ÉîÈëÆÊÎöÁËÐԱ𡢡¢ÖÖ×åºÍµØÀíλÖõȶàÖÖÒòËØ¶Ô½üÊÓ»¼²¡ÂʵÄÓ°Ïì¡£¡£¡£¸ÃÑо¿ÎªÈ«Çò¶ùͯÇàÉÙÄêÊÓÁ¦¿µ½¡ÏÖ×´ÌṩÁËÖÜÈ«µÄÖ¤¾Ý¡£¡£¡£ÑÖ¤Ö¤¾Ý½¨Ò飬¶ùͯºÍÇàÉÙÄêÓ¦ÔöÌí»§Íâ»î¶¯£¬ïÔÌÆÁĻʱ¼ä¡£¡£¡£¿£¿£Ë¼Á¿µ½Éç»á¡¢¡¢¾¼ÃºÍÎÄ»¯Åä¾°²î±ð£¬ÔÚ¹«¹²ÎÀÉú¾öÒéÖУ¬Ïà¹Ø²¿·ÖÓ¦µ±Ô½·¢ÖØÊÓÇøÓò»¯µÄ½üÊÓÔ¤·ÀÕ½ÂÔ£¬ÒÔÔ½·¢ÓÐÕë¶ÔÐÔºÍÎÞаµÄ·½Ê½Ó¦¶ÔÈÕÒæÑÏÖØµÄÊÓÁ¦¿µ½¡ÌôÕ½¡£¡£¡£
ngµç×ÓÓÎÏ·¹«¹²ÎÀÉúѧԺ²©Ê¿ÉúÁº¾°ºê¡¢¡¢Ë¶Ê¿ÉúÆÕÓçù¡¢¡¢³Â¼ÑçùΪ±¾ÎĵÄÅäºÏµÚÒ»×÷Õߣ¬³ÂÑǾü½ÌÊÚΪÂÛÎĵÄΨһͨѶ×÷Õß¡£¡£¡£¸ÃÑо¿Êܵ½¹ú¼Ò×ÔÈ»¿ÆÑ§ÏîÄ¿¡¢¡¢¹ã¶«Ê¡×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿µÄÖ§³Ö¡£¡£¡£
ÂÛÎÄÁ´½Ó£º£º£ºhttps://bjo.bmj.com/content/bjophthalmol/early/2024/08/14/bjo-2024-325427.full.pdf